Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Matson (MATX) Cash & Equivalents (2016 - 2025)

Matson's Cash & Equivalents history spans 17 years, with the latest figure at $141.9 million for Q4 2025.

  • For Q4 2025, Cash & Equivalents fell 46.81% year-over-year to $141.9 million; the TTM value through Dec 2025 reached $141.9 million, down 46.81%, while the annual FY2025 figure was $141.9 million, 46.81% down from the prior year.
  • Cash & Equivalents for Q4 2025 was $141.9 million at Matson, up from $92.7 million in the prior quarter.
  • Across five years, Cash & Equivalents topped out at $609.0 million in Q2 2022 and bottomed at $11.8 million in Q1 2021.
  • The 5-year median for Cash & Equivalents is $138.0 million (2023), against an average of $176.5 million.
  • The largest annual shift saw Cash & Equivalents skyrocketed 3400.0% in 2022 before it crashed 79.97% in 2023.
  • A 5-year view of Cash & Equivalents shows it stood at $282.4 million in 2021, then decreased by 11.54% to $249.8 million in 2022, then crashed by 46.36% to $134.0 million in 2023, then soared by 99.1% to $266.8 million in 2024, then plummeted by 46.81% to $141.9 million in 2025.
  • Per Business Quant, the three most recent readings for MATX's Cash & Equivalents are $141.9 million (Q4 2025), $92.7 million (Q3 2025), and $59.1 million (Q2 2025).